Literature DB >> 23640185

Therapeutic drug monitoring for tomorrow.

Erik Eliasson1, Jonatan D Lindh, Rickard E Malmström, Olof Beck, Marja-Liisa Dahl.   

Abstract

Therapeutic drug monitoring (TDM) represents an early approach to personalised medicine. It helps the clinician to individualise drug treatment and guide dosage to reach systemic drug concentrations associated with therapeutic efficacy and/or to reduce the risk of concentration-dependent adverse effects. Well into the fifth decade of TDM as a service to healthcare, this concept is still expanding, and new areas for clinical implementation continue to emerge. The aim of this overview is to discuss promising new therapeutic areas in future TDM services, how to improve the clinical interpretation of single drug measurements and how recent technology development opens the doors to research and new applications.

Mesh：

Substances：

Year:  2013        PMID： 23640185     DOI： 10.1007/s00228-013-1504-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  42 in total

Review 1.  Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".

Authors:  Finn Bengtsson
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

Review 2.  Current applications of high-resolution mass spectrometry in drug metabolism studies.

Authors:  Markus R Meyer; Hans H Maurer
Journal:  Anal Bioanal Chem       Date:  2012-02-16       Impact factor: 4.142

3.  Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology.

Authors:  Donald Birkett; Kim Brøsen; Ingolf Cascorbi; Lars L Gustafsson; Simon Maxwell; Lembit Rago; Michael Rawlins; Marcus Reidenberg; Folke Sjöqvist; Tony Smith; Petra Thuerman; Andrew Walubo; Michael Orme; Folke Sjöqvist
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-07       Impact factor: 4.080

4.  Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition.

Authors:  Sebastian Broecker; Sieglinde Herre; Bernhard Wüst; Jerry Zweigenbaum; Fritz Pragst
Journal:  Anal Bioanal Chem       Date:  2010-12-03       Impact factor: 4.142

Review 5.  Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale.

Authors:  Sonja Brünen; Philippe D Vincent; Pierre Baumann; Christoph Hiemke; Ursula Havemann-Reinecke
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

6.  Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  D W Duhme; D J Greenblatt; J Koch-Weser
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

7.  Flucytosine therapeutic monitoring: 15 years experience from the UK.

Authors:  A C Pasqualotto; S J Howard; C B Moore; D W Denning
Journal:  J Antimicrob Chemother       Date:  2007-03-05       Impact factor: 5.790

8.  Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.

Authors:  M Eichelbaum; L Bertilsson; L Lund; L Palmér; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

9.  Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Thierry Dugernier; Herbert Spapen; Isabelle Delattre; Xavier Wittebole; Daniel De Backer; Brice Layeux; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-07-01       Impact factor: 9.097

10.  The largest prospective warfarin-treated cohort supports genetic forecasting.

Authors:  Mia Wadelius; Leslie Y Chen; Jonatan D Lindh; Niclas Eriksson; Mohammed J R Ghori; Suzannah Bumpstead; Lennart Holm; Ralph McGinnis; Anders Rane; Panos Deloukas
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113
View more
  14 in total

1.  In vivo Raman measurement of levofloxacin lactate in blood using a nanoparticle-coated optical fiber probe.

Authors:  Shupeng Liu; Ming Rong; Heng Zhang; Na Chen; Fufei Pang; Zhenyi Chen; Tingyun Wang; Jianshe Yan
Journal:  Biomed Opt Express       Date:  2016-02-08       Impact factor: 3.732

2.  A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?

Authors:  Federico Pea; Piergiorgio Cojutti; Lucia Dose; Massimo Baraldo
Journal:  Br J Clin Pharmacol       Date:  2015-12-05       Impact factor: 4.335

3.  SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.

Authors:  Lihong Shi; Miaomiao Zhu; Huilan Li; Zhipeng Wen; Xiaoping Chen; Jia Luo; Cong Lin; Zanling Zhang
Journal:  Eur J Clin Pharmacol       Date:  2019-01-28       Impact factor: 2.953

4.  External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.

Authors:  Jun-Jun Mao; Zheng Jiao; Hwi-Yeol Yun; Chen-Yan Zhao; Han-Chao Chen; Xiao-Yan Qiu; Ming-Kang Zhong
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

5.  Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.

Authors:  Michel Arvidsson; Marja-Liisa Dahl; Olof Beck; Gerd Ackehed; Karin Nordin; Staffan Rosenborg
Journal:  Eur J Clin Pharmacol       Date:  2019-11-30       Impact factor: 2.953

6.  Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis.

Authors:  Susanna M Wallerstedt; Jonatan D Lindh
Journal:  Ther Drug Monit       Date:  2015-08       Impact factor: 3.681

7.  Development of a computerised decisions support system for renal risk drugs targeting primary healthcare.

Authors:  Anders Helldén; Fadiea Al-Aieshy; Pia Bastholm-Rahmner; Ulf Bergman; Lars L Gustafsson; Hans Höök; Susanne Sjöviker; Anders Söderström; Ingegerd Odar-Cederlöf
Journal:  BMJ Open       Date:  2015-07-06       Impact factor: 2.692

8.  Arterial blood gas analysis and the outcome of treatment in tricyclic antidepressants poisoned patients with benzodiazepine coingestion.

Authors:  Ahmad Yaraghi; Nastaran Eizadi-Mood; Maryam Katani; Shadi Farsaei; Mahrang Hedaiaty; Seyyed Mohammad Mahdy Mirhosseini; Elham Beheshtian; Ali Mohammad Sabzghabaee
Journal:  Anesthesiol Res Pract       Date:  2015-01-08

9.  Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman.

Authors:  Mohammed Al Za'abi; Juhina Al Muqbali; Khalid Al-Waili
Journal:  Saudi Pharm J       Date:  2014-11-24       Impact factor: 4.330

10.  Therapeutic Drug Monitoring of Tigecycline in 67 Infected Patients and a Population Pharmacokinetics/Microbiological Evaluation of A. baumannii Study.

Authors:  Tianli Yang; Hekun Mei; Jin Wang; Yun Cai
Journal:  Front Microbiol       Date:  2021-06-16       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.